Skip to content

Propofol in Emergence Agitation

Does a Single Dose of Propofol Decrease the Incidence of Emergence Agitation in Children?

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00535613
Enrollment
99
Registered
2007-09-26
Start date
2007-08-31
Completion date
2010-12-31
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergence Agitation

Brief summary

The purpose of the study is to see if a small dose of propofol given intravenously (through a needle into a vein) at the end of anesthesia can make it less likely that children will be agitated as the come out of the anesthetic.

Detailed description

Emergence agitation is defined as a mental disturbance during the recovery from general anesthesia. It consists of confusion, disorientation, delusions, and hallucinations. It manifests in children as some combination of restlessness, moaning, inconsolable crying, involuntary physical activity, and thrashing about. This puts patients at risk of injuring themselves or their caregivers, causing bleeding or disruption of their surgical repair, and pulling out IVs and drains. It can be difficult to maintain necessary vital sign monitoring in these agitated patients, and constant one-on-one nursing is often required. When emergence agitation occurs, all members of the healthcare team, and the parents report dissatisfaction with the quality of the child's recovery from anesthesia. Propofol is a commonly used intravenous anesthetic agent. Studies have compared continuous infusions of intravenous propofol versus inhalational sevoflurane for the maintenance of anesthesia. These have shown a significant decrease in the incidence of emergence agitation in the patients who received the propofol infusions. This proposed study will investigate the effects of a single bolus dose of propofol at the conclusion of a sevoflurane inhalational anesthetic.

Interventions

DRUGPropofol

IV, single bolus at completion of anesthetic, 0.1 ml/kg

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
12 Months to 6 Years
Healthy volunteers
No

Inclusion criteria

* Age: 12 months to 6 years old * Planned surgery/procedure: The goal is to enroll patients who will not have pain when they awake from anesthesia. We will include patients who are having magnetic resonance imaging (MRI) under anesthesia, or an eye exam under anesthesia. We will also include those patients who are having a surgery in which a regional or caudal block is part of the planned anesthetic. This will be small orthopedic procedures in the lower extremities; or urologic or general surgical procedures below the level of the umbilicus. These patients have been chosen because the regional/caudal block should result in the patient not having pain when they awake from anesthesia. (The caudal block is a single epidural injection of local anesthetic that is done when the pediatric patient is under general anesthesia. It is a routine procedure that results in numbness below the level of the umbilicus, and gives relief of pain, for about 8 hours.) Examples of orthopedic surgeries include, but are not limited to: Removal of an extra digit or syndactyly repair Club foot releases Lower extremity tendon releases or lengthenings Lower extremity tendon transfers Removal of hardware Examples of urologic surgeries include, but are not limited to: Circumcision or circumcision revision hypospadias repair Chordee repair Orchiopexy Orchiectomy Examples of general pediatric surgeries include, but are not limited to: Inguinal hernia repair Rectal muscle biopsies Excision of lower extremity or lower abdominal mass Burn scar releases and skin grafting

Exclusion criteria

* Obstructive sleep apnea-Patients with sleep apnea are not ideal candidates for removal of their endotracheal tube or laryngeal mask airway while still somewhat anesthetized. It is preferable to extubate these patients awake. * Developmental delays-Patients with developmental delays may not interact with their environment, make eye contact, have purposeful actions, or be aware of their surroundings even when at their baseline pre-operatively. It would be difficult to evaluate these features of emergence agitation in children who demonstrate this behavior on a routine basis. * Psychological disorders-Patients with psychological disorders may have the same issues as those with developmental delays when it comes to evaluating their behavior after anesthesia. * Egg white allergy-Propofol is contraindicated in patients with egg white allergies due to risk of allergy to the propofol lecithin base.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Emergent Agitationup to 30 min post surgeryIncidence of Emergent Agitation is defined as a Paediatric Anaesthesia Emergence Delirium (PAED) score above 10 at any point at the defined protocol time points (recovery, 5, 10, 15, 20, 25, or 30 minutes)

Secondary

MeasureTime frame
Time Spent in Recovery Roomup to 1 hour post surgery
Number of Participants Who Received Medication in the Recovery Roomup to 1 hour post surgery

Countries

United States

Participant flow

Participants by arm

ArmCount
Propofol
Propofol: IV, single bolus at completion of anesthetic, 0.1 ml/kg
49
Placebo
No propofol
50
Total99

Baseline characteristics

CharacteristicPlaceboTotalPropofol
Age, Continuous1.72 years1.80 years1.88 years
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
50 participants99 participants49 participants
Sex: Female, Male
Female
2 Participants4 Participants2 Participants
Sex: Female, Male
Male
48 Participants95 Participants47 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 490 / 50
other
Total, other adverse events
0 / 490 / 50
serious
Total, serious adverse events
0 / 490 / 50

Outcome results

Primary

Number of Participants With Emergent Agitation

Incidence of Emergent Agitation is defined as a Paediatric Anaesthesia Emergence Delirium (PAED) score above 10 at any point at the defined protocol time points (recovery, 5, 10, 15, 20, 25, or 30 minutes)

Time frame: up to 30 min post surgery

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
PropofolNumber of Participants With Emergent Agitation16 Participants
PlaceboNumber of Participants With Emergent Agitation24 Participants
Secondary

Number of Participants Who Received Medication in the Recovery Room

Time frame: up to 1 hour post surgery

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
PropofolNumber of Participants Who Received Medication in the Recovery Room3 Participants
PlaceboNumber of Participants Who Received Medication in the Recovery Room6 Participants
Secondary

Time Spent in Recovery Room

Time frame: up to 1 hour post surgery

Population: The study team planned to collect post anesthesia care unit discharge time from the subject medical records, however PACU discharge time was often not recorded in routine cases during the study period. This was not anticipated by the study team and retrospective analysis was not possible for this outcome.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026